CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Open-market sale Chief Financial Officer sold 343 shares at $240.21 ($82,392)
- 10-K Report Annual Report
- 8-K Event Results of operations · Other events
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 8-K Event Other events
- 4 Open-market sale Director sold 5,000 shares at an average $260.52 ($1,302,585)
- 4 Open-market sale Chief Executive Officer sold 20,391 shares at an average $248.51 ($5,067,449)
- 4 Open-market sale Director sold 5,000 shares at an average $251.36 ($1,256,799)
- 8-K Event Other events
- 4 Open-market sale Chief Executive Officer sold 9,609 shares at an average $224.43 ($2,156,572)
- 8-K Event Other events
- 4 Open-market sale Director sold 3,013 shares at an average $211.33 ($636,723)
- 4 Gift Director gave 52,000 shares (gift)
- 8-K Event Other events
- 4 Open-market sale Director sold 1,987 shares at $210.14 ($417,541)
- 4 Open-market sale Chief Executive Officer sold 29,928 shares at an average $206.84 ($6,190,334)
Page 27 of 64 · 1,278 filings